Protagonist Therapeutics (PTGX) Long-Term Investments (2016 - 2026)
Protagonist Therapeutics (PTGX) reported Long-Term Investments of $66.9 million for Q2 2026, down 34.7% from $102.5 million a year earlier and down 7.8% from the prior quarter.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Long-Term Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Protagonist Therapeutics posted Long-Term Investments of $78.64 million, down 44.0% from FY2024.
- Long-Term Investments has a five-year compound annual growth rate of 108.4% (FY2020 to FY2025).
- By year, Long-Term Investments came in at $140.3 million in FY2024.
- The Q2 2026 figure ranks as the lowest quarterly Long-Term Investments since Q2 2024.
- Year over year, Long-Term Investments has now declined in each of the last four quarters, with growth averaging 19.1% over the last five quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $72.55 million (Q1 2026), $78.64 million (Q4 2025) and $102.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.62 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Protagonist Therapeutics | 9.00 Bn | 9.00 Bn | - | 66.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.90 Mn |
| Mar 31, 2026 | 72.55 Mn |
| Dec 31, 2025 | 78.64 Mn |
| Sep 30, 2025 | 102.70 Mn |
| Jun 30, 2025 | 102.50 Mn |
| Mar 31, 2025 | 123.52 Mn |
| Dec 31, 2024 | 140.30 Mn |
| Sep 30, 2024 | 114.60 Mn |
| Jun 30, 2024 | 31.45 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Sep 30, 2021 | 38.20 Mn |
| Jun 30, 2021 | 26.12 Mn |
| Mar 31, 2021 | 6.30 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2020 | 6.03 Mn |
| Mar 31, 2018 | 5.56 Mn |
| Dec 31, 2017 | 11.46 Mn |
| Sep 30, 2017 | 11.32 Mn |
| Mar 31, 2017 | 14.00 Mn |
| Dec 31, 2016 | 10.15 Mn |
API Access
Protagonist Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=PTGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "PTGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=PTGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();